Stimuli-responsive conductive hydrogels have emerged as a new rising concept in the
hydrogel research field due to their combined advantages of stimuli-responsivity and …

The development of antiretroviral therapy for the prevention and treatment of HIV infection
has been marked by a series of remarkable successes. However, the efforts to develop a …

Drug-eluting implants are one of the leading implant technologies to facilitate the healing
capacity of bones by eliminating implant-associated infections. Treatment of the infections …

Non-oral long-acting drug delivery systems (LADDS) encompass a range of technologies for
precisely delivering drug molecules into target tissues either through the systemic circulation …

The long-acting antiretroviral cabotegravir and rilpivirine combination has just received FDA,
EMA and Health Canada approval. This novel drug delivery approach is about to …

Polymeric in situ forming depots have emerged as highly promising drug delivery systems
for long-acting applications. Their effectiveness is attributed to essential characteristics such …

Poly (lactic-co-glycolic acid)(PLGA) is used in vivo for various biomedical applications. Due
to its biodegradability and biocompatibility, PLGA is uniquely suited for controlled drug …

Implantable medical devices (IMDs) are designed to sense specific parameters or stimulate
organs and have been actively used for treatment and diagnosis of various diseases. IMDs …

In situ forming implants, defined as liquid formulations that generate solid or semisolid
depots following administration, have shown a range of advantages in drug delivery. This …

Introduction Poly (lactic-co-glycolic acid)(PLGA) has been used in many long-acting drug
formulations, which have been approved by the US Food and Drug Administration (FDA) …